Petros Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $8.0M | $2.1M |
| FY2020 | — | $17.5M | $17.1M |
| FY2021 | — | $35.5M | $23.8M |
| FY2022 | — | $16.7M | $9.4M |
| FY2023 | — | $12.1M | $13.3M |
| FY2024 | — | $-7.5M | $1.7M |
| FY2025 | — | $2.9M | $5.1M |